$10.91
-0.32-2.85%
At Close: -
$10.92
0.01000.09%
After Hours: Sep 20, 4:16 PM EDT
15 minutes delayed
Comments
Loading...
Replimune Group (REPL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestReplimune Group (NASDAQ:REPL) Stock Quotes, Forecast and News Summary
Replimune Group Stock (NASDAQ: REPL) stock price, news, charts, stock research, profile.
| Open | $11.17 |
| Close | $10.91 |
| Volume / Avg. | 3.73M / 826.64K |
| Day Range | $10.90 - $11.33 |
| 52 Wk Range | 4.92 - 17.93 |
| Market Cap | $746.07M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 56 |
| Short Interest | 11.09% |
| Days to Cover | 9.69 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Replimune Group Inc
Sector
Health Care
Industry
Biotechnology
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Replimune Group (REPL) stock?
You can purchase shares of Replimune Group (NASDAQ:REPL) through any online brokerage.
Who are Replimune Group (REPL) competitors?
Other companies in Replimune Group’s space includes: 89bio (NASDAQ:ETNB), Humacyte (NASDAQ:HUMA), 4D Molecular Therapeutics (NASDAQ:FDMT), Tango Therapeutics (NASDAQ:TNGX) and Mesoblast (NASDAQ:MESO).
What is the forecast, or price target, for Replimune Group (REPL) stock?
There is no analysis for Replimune Group to provide a consensus price target.
What is the current price for Replimune Group (REPL)?
The stock price for Replimune Group (NASDAQ: REPL) is $10.92 last updated September 20, 2024 at 4:16 PM EDT.
Does Replimune Group (REPL) pay a dividend?
There are no upcoming dividends for Replimune Group.
When is Replimune Group (NASDAQ:REPL) reporting earnings?
Replimune Group’s Q2 earnings are confirmed for Tuesday, November 5, 2024.
Is Replimune Group (REPL) going to split?
There is no upcoming split for Replimune Group.
What sector and industry does Replimune Group (REPL) operate in?
Replimune Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.